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Abstract
Short AT base pair sequences that are separated by a small number of GCs are common in
eukaryotic parasite genomes. Cell-permeable compounds that bind effectively and selectively to
such sequences present an attractive therapeutic approach. Compounds with linked, one or two
amidine-benzimidazole-phenyl (ABP) motifs were designed, synthesized and evaluated for
binding to adjacent AT sites by biosensor-surface plasmon resonance (SPR). A surprising feature
of the linked ABP motifs is that a set of six similar compounds has three different minor groove
binding modes with the target sequences. Compounds with one ABP bind independently to two
separated AT sites. Unexpectedly, compounds with two ABP motifs can bind strongly either as
monomers or as cooperative dimers to the full site. The results are supported by mass
spectrometry and circular dichroism, and models to explain the different binding modes are
presented.
INTRODUCTION
The concept of specific control of cellular gene expression by designed compounds is a key
goal of chemical biology and offers many advantages in the development of new types of
drugs as well as agents for biotechnology. The control could be affected, for example, by
directly targeting genes with designed oligomers, such as PNA,1,2 or with a variety of small
molecules.3–5 Sequences for most of the 20–25 thousand human genes are now known and
all of them are potentially susceptible to external control.6 The sequences of the genomes of
a large number of disease causing microorganisms have also been determined and offer
selective strategies to control or destroy the organisms.7,8 Designed compounds that have
biological activity against either duplex,4,5,9–12 triplex and triplet-repeat DNA,13,14 or
quadruplex DNA structures15–19 have also been identified and are under development.
The design of optimum compounds to target DNA for a therapeutic outcome must obey
several rules. The compounds obviously must be cell permeable and this limits the group
types that can be combined on a core compound template. The compounds must be large
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enough to give sufficient affinity and selectivity to generate activity while maintaining low
toxicity. The cost of synthesis can also be a factor, especially for compounds that are
designed for use against diseases such as malaria and sleeping sickness that affect many of
the world’s most financially depressed regions.
With these constraints as limiting features we have focused in this work on the design of
relatively simple compounds that can selectively target a 10 base pair sequence in the minor
groove of DNA. In order to uniquely bind to a site in the entire human genome about 15–16
base pairs must be in the binding site.20 If we focus on genes and their control sequences
while recognizing that not all genes are expressed in a specific cell, that number is reduced.
Although the design concepts are general and could be extended to target DNA in a variety
of cells, we have specifically focused on the mitochondrial kinetoplast genome of
trypanosomes as an optimum, initial test system.11,21–23 The kinetoplast consists of
thousands of interlocked AT-rich DNA minicircles that code for guide RNAs that control
mRNA editing.1,24 The mRNAs are coded by maxicircle DNA that are also part of the
kinetoplast matrix. The possibility of targeting the kinetoplast as a unique DNA target
structure is recognized,11,21–23 but new drugs to selectively target the unusual structure have
not yet reached the final approval stage.25 For the small mitochondrial genomes of these
parasitic microorganisms, a 10 base pair target site can give the desired selectivity.20
Trypanosomes cause sleeping sickness (T. brucei) in Africa25 and Chagas disease (T. cruzi)
from the southern United States to Argentina.26 The organisms infect and kill many
thousands of people each year and current drugs to treat the associated diseases have serious
limitations from toxicity to resistance.11,25,27
Both the kinetoplast of trypanosomes and the nuclear genome of malaria are quite AT rich
with significant regions of AT base pairs separated by a small number of GC base
pairs.9,11,21,22,24 To simplify and reduce the costs of synthesis, symmetric compounds have
been prepared (Figure 1). With appropriate linking groups the symmetry of such compounds
makes them ideal for targeting two AT sites separated by GC base pairs. The amidine-
benzimidazole-phenyl (ABP) motif is effective for targeting AT sites in DNA and we have
incorporated that motif in our design strategy. In an initial set of test compounds, the
symmetric compounds RT546, DB2114, DB2115 and DB2119 were designed with two ABP
motifs, to specifically target two AT sequences with a flexible linker to connect them across
one or more GC base pairs (Figure 1). Compounds DB184 and RT533, with single ABP
motifs, are included as controls. The concept of connecting recognition units to recognize
two or more sites in proteins or DNAs has been used in other systems.28 In DNA,
combilexins connect an intercalator and minor groove binding agent;29–31 bis-or
polyintercalators can intercalate and bind in both the major and minor grooves;32–35 minor
groove alkylating groups can be placed on two linker groove recognizing units to alkylate at
two sites;12,36 and linked polyamide minor groove agents can also bind at adjacent sites.37
The key questions that we wish to address with these compounds are (i) what level of
binding affinity can be obtained with compounds of this type and DNA sequences
containing AT base pair sites separated by one or more GC base pairs which are common in
the parasitic organisms (Figure 1); (ii) do the compounds fold back through the flexible
linkers to bind to single AT sites or can a single compound bind to both of the AT sites as
desired; and (iii) for compounds that can bind simultaneously to both sites, what correlation
is there between linker length, rigidity and the number of GC pairs between the AT sites?
These questions can be answered with the designed set of compounds in Figure 1. The
results presented here are quite surprising and show that even this small set of compounds
has unique interactions with DNA including three completely different binding modes, even
with the relatively simple set of DNA sequences in Figure 1.
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Syntheses of DB2114, DB2115 and DB2119 were done much the same as with published
compounds DB184, RT546 and RT533,38,39 and the detailed syntheses are described in the
Supporting information. The purity of all compounds was verified by NMR and elemental
analysis.
In SPR experiments, 5′-biotin labeled hairpin DNA oligomers were used (DNA sequences
shown in Figure 1B). In MS, CD and Tm experiments, the hairpin DNA oligomers used
were AATT [5′-GGAATTCGCTCTCGAATTCC-3′], AATTGAATT [5′-
GGAATTGAATTCGCTCTCGAATTCAATTCC-3′] and AATTGCAATT [5′-
GGAATTGCAATTCGCTCTCGAATTGCAATTCC-3′] with the hairpin loop sequences
underlined. All DNA oligomers were obtained from Integrated DNA Technologies, Inc.
(IDT, Coraville, IA, USA) with reverse phased HPLC purification and mass spectrometry
characterization. The CCL10 buffers used in CD and Tm experiments contained 0.01 M
cacodylic acid, 0.001 M EDTA, 0.1 M NaCl, pH 6.25. The SPR experiments were
performed in filtered, degassed CCL10 buffer with 5×10−3% v/v Surfactant P20 and 0.1M
ammonium acetate, pH 7.0 was used in MS experiments.
Biosensor-Surface Plasmon Resonance (SPR) studies
SPR measurements were performed with a four-channel Biacore T100 or T200 optical
biosensor system (Biacore, GE Healthcare Inc.). 5′-biotin labeled DNA samples [AATT,
AATTGAATT, AATTGCAATT, AATTGCGAATT, AATTGCGCAATT,
AATTGCGCGAATT, AATTGCGCGCAATT hairpins] were immobilized onto
streptavidin-coated sensor chips (Biacore SA) as previously described.40,41 Three flow cells
were used to immobilize the DNA oligomer samples, while a fourth cell was left blank as a
control. SPR binding analysis was performed with multiple injections of different compound
concentrations over the immobilized DNA surface at a flow rate of 25 μl/min and 25 °C. For
steady-state analysis the number of binding sites and the equilibrium constant were obtained
from fitting plots of RU versus Cfree. Binding results from the SPR experiments were fit
with one- (K2=0) or two-site interaction models:
(1)
where r represents the moles of bound compound per mole of DNA hairpin duplex, K1 and
K2 are macroscopic binding constants, and Cfree is the free compound concentration in
equilibrium with the complex.41,42 Kinetics fits were used when no steady state was reached
as previously described.41,43
Electrospray mass spectrometry (ESI-MS) studies
ESI-MS experiments were performed on a Q-TOF micro (Waters Micromass, Manchester,
UK) with its standard ESI source and general published procedures for DNA.44,45 The
electrospray source was operated in the negative ion mode with a needle voltage of −2.2 kV.
The cone voltage was set to −30 V, and the RF lens1 voltage to −60 V. The hexapole
collision voltage of 3 V and the ion energy of 1.5 V were used for full scan MS. Source
block and desolvation temperatures were set to 70 °C and 100 °C, respectively. Spectra were
acquired from 200 to 3200 m/z and only a portion of the mass range was shown for clarity.
DNA oligomers were dialyzed in 0.1M ammonium acetate, pH 7.0, using Spectra/Por® 7
dialysis membranes (molecular weight cut off: 1000 daltons, Spectrum laboratories, Inc.,
CA, USA) to remove the nonvolatile ions. Experiments were generally conducted at a
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concentration of 5 × 10−6 M for hairpin DNA and the ratios of compound to DNA (1:1, 2:1
and 3:1) were obtained by adding compound to DNA solution.
CD titration studies
CD spectra were recorded using a Jasco J-810 instrument with a 1cm cell and a scan speed
of 50 nm/min with a response time of 1 s. The spectra from 500 to 220 nm were averaged
over five scans. A buffer baseline scan was collected in the same cuvette and subtracted
from the average scan for each sample. The titration experiments were performed at 25 °C.
The desired ratios of compound to DNA were obtained by adding compound to the cell
containing a constant amount of DNA and in all cases the absorbance was kept below 1.0.
Data processing and plotting were performed with Kaleidagraph software.
Molecular Docking
Molecular docking and visualization experiments were performed with the SYBYL-X1.2
software package on a Windows 8 processor Workstation.46 The initial DNA duplexes 5′-
d(GGAATTGAATTCG)-3′ and 5′-d(GGAATTGCAATTCG)-3′ were constructed in the
Biopolymer-Build DNA Double Helix module employing regular B-DNA parameters. In
order to accommodate two ligands binding in the minor groove of the duplex 5′-
d(GGAATTGCAATTCG)-3′ the define distance-dependent constraints option was used to
widen the minor groove. Two different models were constructed. The middle six base pairs
were widened for the overlapped model (See Results for model descriptions), while the only
four base pairs were widened for the offset model. The groove was then allowed to decrease
to the original width. These three DNA sequences were next energy minimized for a
maximum of 100 iterations using the conjugate gradient algorithm and Tripos force field,
with a termination gradient of 0.1 kcal/(mol Å). RT546 was assigned Gasteiger-Hückel
charges and minimized using the Tripos force field until a terminating conjugate gradient of
0.01 kcal/mol Å or the maximum 1000 iterations was reached.47
To help position the bound compound in the AATTGAATT site, the crystal structure, 3GJH,
a 6-amidine-2-(4-amidino-phenyl)indole in complex with 5′-d(CGCGAATTCGCG)-3′
from the protein data bank, was selected. The DNA duplex containing the AATTGAATT
site was aligned to the crystalized sequence such that AATT sites were overlayed and the
DNA sequence from 3GJH was removed. This process was then repeated at the second
AATT. A protomol was generated using a ligand-based approach with the Surflex-Dock
module. During the protomol generation, the two parameters “Threshold” and “Bloat” were
set to 0.5 and 2, respectively. “Threshold” determines how much the protomol extends into
the minor groove, while “Bloat” impacts how far the protomol expands in three-dimensional
space. All other parameters were left at the default values. After generation of the protomol
the GeomX module was used to dock RT546 (Figure 1).48,49
The two AATTGCAATT duplexes were used with the RT546 dimer and the compound was
manually docked to the widened minor groove. The complex was minimized with DNA
fixed until a derivative of 0.01 kcal/mol Å was reached. Before each docking, the RT546
dimer was moved to a separate molecular area, so that the ligands can be moved
independently of the DNA.47 The genetic algorithm of the Flexidock module was employed
implementing five different random numbers and 678, 000 generations. 47,50 Both the
ligands and the bound DNA were permitted torsional flexibility in the docking process.
Atomic charges were computed using the Kollman all-atom for DNA and Gasteiger-Hückel
for the ligands. All the possible hydrogen-bond sites were selected for the DNA-compound
complex. From each docking, the 20 lowest-energy structures were selected.
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Biosensor-Surface Plasmon Resonance: determining binding affinity, stoichiometry and
cooperativity
SPR experiments were used to quantitatively compare binding affinity, stoichiometry and
cooperativity of compound interactions with immobilized AATT and AATTGCAATT
sequences (Figure 2).40,41,43 Essentially the same moles of the DNA oligomers were
immobilized on the surface of each sensor chip so that the sensorgram saturation levels can
be compared directly for stoichiometry. The differences in interaction strength and binding
stoichiometry for four example compounds are visualized in a plot of r (moles of compound
bound/mole of hairpin DNA) versus Cfree, the free compound concentration (Figure 2B).
The plots were best fit with a one-site binding model for AATT and a two-site binding
model for AATTGCAATT (K values are summarized in Table 1).
The relative values of the macroscopic equilibrium constants, K1 and K2, also reflect the
cooperativity of the interaction. A cooperativity factor to assess the degree of cooperativity
is defined as, CF = (K2/K1) × 4. CF is equal to 1 for interactions with no cooperativity,
greater than 1 for positive cooperativity and less than 1 for negative cooperativity. As can
been seen in Figure 2 and Table 1, DB184 binds AATT as a monomer and AATTGCAATT
at two sites without cooperativity, as expected. In a similar manner RT533 binds AATT very
strongly as a monomer, while it binds AATTGCAATT as a 2:1 complex with no significant
cooperativity. Surprisingly, the linked compound, RT546, binds in a completely different
manner, as a weak monomer to AATT, but as a strong dimer with positive cooperativity to
AATTGCAATT (CF > 3000). DB2119, with a more rigid linker, does not bind to AATT
while it also binds to AATTGCAATT as a dimer with positive cooperativity, as with
RT546. These SPR results are supported by thermal melting studies. DB184 has a very
small increase in Tm in agreement with its weak binding by SPR. Both RT546 and DB 2119
have biphasic curves in agreement with their positive binding cooperativity. DB533 has a
monophonic curve in agreement with its lack of binding cooperativity (Supplementary
Materials, Figure S1). Tm curves for all of the two-site compounds do not have an
observable high temperature baseline and the Tm values cannot be determined accurately. It
is clear, however, that the Tm increases scale in the same general order as binding constants.
SPR sensorgrams were also obtained for two additional DNAs; a sequence of similar length
without a GC linker, A5T5, and a sequence with one AATT binding site mutated to AGTC,
AATTGCAGTC (Figure S2, Supporting information). RT546 and DB2119 bind strongly as
monomers to A5T5 (Figure S2, Supporting information). RT533 binds A5T5 as a 2:1
complex with negative cooperativity. With AATTGCAGTC RT546 and RT533 bind as
monomers with binding constants very close to the values for a single site AATT (Table 1
and Figure 2). As with AATT, no binding is observed for DB2119 with AATTGCAGTC,
(Figure S2, Supporting information).
In additional studies with DNA sequences that have an extended GC linker length, it was
observed that the linker length has no significant effect on binding of the control
compounds, DB184 and RT533 (Table 1). As the GC length increases, RT546 still forms a
2:1 complex but with decreasing cooperativity. Figure S3 (Supporting information) shows
that both the association and dissociation rates increase for RT546 binding with 0 to 3 GC.
DB2119, however, loses significant binding affinity and cooperativity with increasing GC
length and has no detectible binding for the 5 and 6 GC base pair spacer (Table 1).
To investigate how the linker length in RT546 affects the DNA recognition pattern, two
longer compounds with one (DB2115) and two (DB2114) additional -CH2- groups were
synthesized. For the linker [-O-(CH2)n-O-] the binding affinity and cooperativity for DNA
sequences can vary by a surprisingly large amount as n increases from 3 to 5 (Figure 3,
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Table S1, Supporting information). RT546, n = 3, binds AATT as a weak monomer, for
example, while no binding is observed for the longer compounds, DB2115 and DB2114 (n =
4 or 5). With AATTGAATT all three compounds bind strongly as monomers and with
AATTGCAATT all three bind as cooperative 2:1 dimers. As can be seen in Figure 3B and
Table S1, the three compounds slightly lose binding affinity for AATTGCAATT when the
linker length is increased and the cooperativity for binding decreases significantly (about
100 times) as n increases from 3 to 5. Apparently, RT546 has an optimum linker length in
this general structure and has the highest binding affinity and cooperativity for a 2:1
complex with AATTGCAATT.
Electrospray Ionization Mass Spectrometry (ESI-MS): Characterizing the binding
stoichiometry and cooperativity
ESI-MS experiments allow the resolution of complex mixtures and determination of
stoichiometries and any binding cooperativity for complexes that are present simultaneously
in an injected sample.44,45 Figure S4A (Supporting information) shows ESI-MS spectra of
AATT with the three linked compounds RT546, RT533 and DB2119 at different compound
to DNA ratios. A high intensity 1:1 complex is detected for RT533, only a low intensity 1:1
complex peak is observed for RT546 and no peak is observed for DB2119. Figure S4B
(Supporting information) shows ESI-MS spectra of AATTGAATT with the same
compounds. Peaks for both a 1:1 (labeled as blue) and a 2:1 complex (labeled as red) can be
observed for RT533, even at low compound to DNA ratios. As the ratio is increased, the
intensity of the 2:1 complex peak increases, but no higher order complexes are observed.
For RT546 and DB2119, only a 1:1 complex peak is observed as the ratio increases,
indicating a monomer complex. ESI-MS results for AATTGCAATT with the three
compounds RT546, RT533 and DB2119 are summarized in Figure S4C (Supporting
information). For RT546, the peak for the 2:1 complex is much larger than the 1:1 complex
peak indicating strong cooperative dimer formation. With RT533, the peak for the 1:1
complex is much larger than the peak for the 2:1 complex at low compound to DNA ratios.
With increasing ratio the peak for the 2:1 complex increases, and the 1:1 complex peak
decreases. This clearly shows that RT533 binds to AATTGCAATT as a 2:1 complex with
no cooperativity. For DB2119 only the peak of the 2:1 complex is detected as the compound
to DNA ratio increases, indicating that DB2119 binds to AATTGCAATT as a dimer with
very strong positive cooperativity. To visualize the different stoichiometries for
AATTGCAATT and AATT binding with the three linked compounds more easily, ESI-MS
spectra of three DNA sequences with RT546, RT533 and DB2119 at a 2:1 ratio (compound
to DNA) are compared in Figure 4. All of these results are in excellent agreement with the
findings from SPR.
Circular Dichroism (CD): Probing the binding mode and binding ratio
CD spectra monitor the asymmetric environment of the compounds when bound to DNA
and therefore can be used to obtain information on the binding mode.51 Free RT546 does not
exhibit CD signals; however, upon addition of the compound to AATTGCAATT,
substantial, positive induced CD signals arise in the compound absorption region between
300 and 400 nm (Figure S5A, Supporting information). These positive induced CD signals
for the complexes are characteristic patterns for minor grove binding in AT sequences.51 CD
changes are significantly smaller for AATT than for AATTGCAATT. CD spectra for the
complexes of RT533, RT546 and DB2119 with AATTGCAATT sequence are compared in
Figure S5B (Supporting information) and display large positive induced CD spectral
changes, as expected, for minor groove complexes. For all three compounds the saturation
maximum is 2 compounds/hairpin for AATTGCAATT, and these values are consistent with
the results from SPR experiments. The induced CD signals for DB2119 with a more rigid
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linker are larger than for the more flexible compounds, suggesting a stronger dipole
interaction with the bases in this compound51.
Molecular docking
To provide ideas for a better understanding of the two site binding modes of symmetric
compounds, RT546 was docked into the two AATT sites with G and GC spacing sequences
(Figure 5) as described in the Methods Section (additional views of the models are shown in
Figure S6). The monomer docking at AATTGAATT is similar to classical minor groove
binding compounds (Figure 5A). The groove is relatively narrow along the entire two site
length. The ABP modules fit nicely into the AATT sites with amidine and benzimidazole H-
bonds to the floor of the groove. The trimethylene linker binds into the groove at the GC
base pair as expected. Although minor variations of this model are possible, and certainly
occur on a dynamic basis, any major movement of RT546 in this site results in a significant
loss of binding interactions and is unlikely.
For the AATTGCAATT site two different models with favorable interactions for the RT546
2:1 complex are presented. In Figure 5B the stacked molecules are slightly offset such that
the amidine of the top molecule of the Figure stacks over the benzimidazole of the lower
molecule. At the other end of the dimer the stacking is reversed. This allows amidine and
benzimidazole -NHs of the lower molecule to H bond to AT base pairs at the floor of the
groove, but the imidazole -NH and phenyl of the upper molecule are pulled into the GC
region of the sequence. The alkyl group of the upper molecule is at the top GC base pair in
the site. For the lower molecule the stacking is reversed. All four amidine groups in the
stacked dimer are able to H-bond to AT base edges at the floor of the groove. The central six
base pairs of the minor groove in the AATTGCAATT sequence must be widened to
accommodate the stacked dimer. The groove then rapidly narrows to the normal B-form
width at the ends of the AT binding site and flanking sequences.
In Figure 5C, the AATT regions of groove are narrow, as in all known structures, while the
groove widens at the GC site, also as expected. In order to accommodate two stacked RT546
molecules into this asymmetric groove structure the compound stacking must be
significantly offset. This moves the amidines far apart and reduces electrostatic repulsion. It
allows stacking of two benzimidazole-phenyl units in the wide GC groove. Both amidine
and benzimidazole -NHs in the GC center point toward the GN3 (amidine) or C keto
(benzimidazole NH) groups and are within H-bonding distance. The phenyl oxygens of
these stacked systems are rotated such that the methylene and remaining ABP units are
brought to the center of the AATT sites. The amidine and benzimidazole -NHs that are not
in the GC sequence H-bond to the floor of the groove at AN3 and T keto groups. The central
four base pairs have a wide groove to accommodate the stacked modules and the groove
then quickly narrows to contact the remaining reactions of the compounds in the AT
sequences of the offset dimer. The two stacked dimer complexes at the AATTGCAATT
sequence were docked to provide the best interactions with the DNA sequence. Movement
of the compounds away from these positions results in a significant loss of H-bonding and is
unlikely. To optimize H-bonding with base pair edges at the floor of the groove, the
compounds in the dimer must be moved in specific jumps from interactions with one base
pair to the next. This restriction means that there are very few optimized dimer positions in
the two site sequences and the two shown have the best energetics.
DISCUSSION
The six compounds in Figure 1 were designed to probe the types of linked structures that
can bind strongly to the minor groove in adjacent AT sites of the kind found in the DNA of
parasitic microorganisms. The results provide important and somewhat surprising
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information on how compound molecular structure affects binding to complex, closely
related DNA sequences. The fundamental unit in the compound design is an ABP, amidine-
benzimidazole-phenyl, motif and all compounds have at least one copy of the motif (Figure
1, Tables 1 and S1). As expected from their shape, chemical groups and charge, CD studies
show that all of these compounds bind to the DNA minor groove.51 The results of biosensor-
SPR and mass spectrometry experiments with oligomer DNA models for two-site
kinetoplast DNA binding sites, however, clearly reveal that the different compounds have
quite different structures in complex with DNA.
The simple control compound, DB184, binds relatively weakly to all of the DNAs. It binds
to one site with the AATT DNA and to two sites with no cooperativity with the two site
DNAs by all methods, as expected (Figure 2). This compound thus has essentially “ideal”
independent, multi-site binding properties42 and is a useful control for comparison with the
more complex results for the other compounds (Figure 2). With the linked compounds a
surprisingly large variation in interactions with the model DNAs of Figure 1 is obtained. The
analysis with different DNAs makes it possible to dissect the binding modes of the single
ABP module control compound, RT533. It binds to AATT as a monomer, about 100 times
stronger (K > 108 M−1) than DB184, suggesting that the phenylamidine can fold back to
stack on the benzimidazole-phenyl module with favorable interactions in a single GAATTC
site. A schematic model to illustrate this binding mode is shown in Figure 6 (Model 1). We
suggest that the stacked part of the complex will be closer to the wider GC minor groove and
will be quite dynamic. While the compound may be able to fit the AATT site without
stacking, this would require unfavorable conformational changes in the linker and given the
strong binding, such a complex seems unlikely. RT533 binds to all of the two site sequences
as a strong 2:1 complex indicating that the compound can bind to individual AATT sites in
the two site sequences in much the same way as with the single AATT. It has significant
negative cooperativity in the interaction with the closely spaced sites in AAAAATTTTT and
AATTGAATT, perhaps due to electrostatic repulsion and unfavorable steric effects. The
negative cooperativity decreases with the GC spacer length increase in AATTGCAATT and
no significant cooperativity is observed for the DNAs with longer GC sequences. On the
whole the compound binds similarly to DB184 except that it has larger K values.
The symmetric compounds have two ABP modules and they exhibit very different binding
modes with the different DNA sequences. RT546, which has an O-(CH2)3-O linker, is the
simplest of these compounds and in contrast to RT533 binds to the single AATT DNAs in a
relatively weak 1:1 complex. The restricted conformational space of this compound does not
allow it, or any other symmetric ABP derivative, to fold into a favorable complex with
single AATT sites. RT546, however, binds to AATTGAATT as a strong 1:1 complex, again
in contrast to RT533 which binds as a 2:1 complex. These results again indicate that RT546
is too large to fold back and bind to a single AATT site, as in Figure 6, Model 1. The results
indicate, however, that it can extend its linker through the minor groove at a GC base pair to
bind effectively as a monomer to both AATT sites in the AATTGAATT sequence, as in
Model 2 of Figure 6. The compounds were designed to bind in this manner, ABP units at
AATT and the linker at the GC base pair, and the observed complex is quite satisfying.
To provide a molecular model to help visualize the interactions in the 1:1 complex, RT546
was docked into the AATTGAATT sequence (Figure 5A). The docked model for the
interaction of RT546 with the single GC sequence is similar to classical minor groove
complexes at pure AT sites. The single GC between the narrow AATT units does not
significantly widen the minor groove but forms a binding site for the somewhat more bulky
methylene groups. The lack of widening of the minor groove by a single GC in A-tract
sequences may be a common feature of DNA complexes. A similar lack of groove widening
by a single GC was noted with the Fis transcription factor-DNA complex while insertion of
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three GC base pairs did widen the groove with substantial loss of Fis binding affinity52.
There are limited favorable interactions in this GC part of the complex in Figure 5A and
current design efforts are focused on possible GC recognition units to improve the
interaction. The ABP modules fit into the AATT sites with van der Waals, H bonding and
water displacement contributions to binding affinity. The modules do not, however,
completely fill the length of the AATT site and it is clear that the affinity for the AATT
sequences in AATTGAATT can be also improved.
Analysis of the binding results with AATTGCAATT provided an unexpected surprise. The
expected result was either a 1:1 complex whose strength depended on how the linking chain
could fit into the groove at GC, or no complex if the linker did not fit. Instead we observed a
highly cooperative 2:1 complex. Complexes at the same ratio but with decreasing positive
cooperativity were observed for the other DNAs in Table 1. A schematic model to explain
these results is shown in Figure 6 (Model 3). The stacked dimer in Model 3 is an entirely
new binding mode for dicationic minor groove compounds that bind in A-tract type
sequences. In the molecular docking results in Figure 5 two models for the 2:1 complex of
RT546 at AATTGCAATT are described. The results show that the minor groove with two
GC base pairs between AATT widens such that a stacked complex of RT546 is more
energetically favorable that the monomer binding with a single GC. This widening also
agrees with the Fis-DNA results for more than one GC between AT sequences.52 The two
complexes for RT546 are both able to form a significant number of favorable interactions
with base edges at the floor of the minor groove as well as cation-π interactions in the
stacked dimer. The offset model of Figure 5C appears more favorable than the overlapped
model in Figure 5B for two primary reasons: (i) the charged amidines are close in 5B and
this will give significant electrostatic repulsion; and (ii) to accommodate the model in 5B,
the AATT minor groove must widen to bind the stacked dimer units but this sequence
strongly resists dimer complexes in other systems. Wemmer and coworkers, for example,
observed monomer binding in AATT and only found the distamycin dimer in longer
sequences of A-tract type structures.53 Monomer binding is observed in all AATT minor
groove complexes in the protein data base. The model in 5C retains a narrow groove in the
AATT sites but has the expected wider GC groove. The models again suggest that both GC
and A-site recognition can be significantly improved. The AT recognition part of the
complex does not completely fill the site and expansion of the ABP unit can improve these
interactions. For stacked dimer recognition of the GC spacer, we must make nonsymmetrical
molecules, as with expanded RT533 analogs that have an H bond acceptor for interaction
with the G-NH2. The other molecule of the dimer should have a donor for interaction with
the complementary C=O group. Initial examples of such molecules are in preparation.
Another important observation with RT546 is that as the GC linker length increases, K1 for
the cooperative complex increases while K2 decreases. As a result, the overall binding
constant (K = (K1 × K2)1/2) does not significantly change but the cooperativity factor (CF =
K2/K1 × 4) decreases. This is probably caused by decreased stacking of the ABP modules
with decreased van der Waals interactions (K2 decrease), but favorable, decreased amidine
electrostatic repulsion (K1 increase). Adjustments to optimize binding energetics are also
possible in the alkyl linking chain.
It is somewhat surprising that in the symmetric compounds, changing the length of the
linking chains generally causes a fairly small difference in DNA affinity (Tables 1 and S1).
With the AATTGAATT sequence and the alkyl linked compounds, for example, the five
methylene compound, DB2114, has slightly weaker binding than the four and three
methylene derivatives (Table S1). In contrast, the more rigid five carbon linker in DB2119,
with a central phenyl, causes a tenfold decrease in binding affinity. This finding suggests
that the length and/or flexibility of the phenyl linker are not optimum for binding with a
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single GC base pair spacer. With the AATTGCAATT sequence DB2119 binds much more
strongly and clearly has a better length for this sequence. It binds similarly to the three GC
spacer DNA but the binding constant decreases marked for the longer DNAs in contrast to
the flexible linker compounds. The phenyl liker has much larger restrictions on its two site
interactions but with appropriate optimization, this could provide a powerful ability to target
specific DNA sites, especially since this compound does not significantly bind to single
AATT sites. The flexible compound RT546 has much more similar affinities for all of the
DNA GC spacer lengths and can thus adapt its cooperative dimer formation to a range of
sequences. Such compounds might be best for targeting kinetoplast DNA where binding to
multiple two-site sequences is an advantage.
There are two key points to consider in evaluation of the interaction of these first-generation
compounds with two closely spaced AT sites in terms of designing the second generation of
linked modules for binding to two closely spaced AT sites. First, longer flexible linkers (as
in DB2114) have weaker binding probably due to loss of configurations and entropy on
forming a complex. Such linkers should be avoided when possible. Second, the current
linkers in the ABP compounds do not have favorable GC interactions and serve primarily to
let the two ABP modules fit into the AT sites. Optimization of compounds with appropriate
linker lengths that have specific GC recognition motifs is, thus, a requirement for second
generation compounds. Synthesis of second generation compounds, based on these design
principles, is in progress and should provide new agents with both increased affinity and
specificity.
In summary, linked two-site binding compounds such as those in Figure 1 can have three
major, different types of complexes with A-tract sequences in DNA. There are two
particularly unexpected features of the results. First is the switch from monomer binding by
the compounds with two ABP motifs, when there is a single GC between AATT target sites,
to dimer binding with a two GC spacer in the DNA sequence. Clearly the widening of the
groove with the two GCs allows the compound to improve the total free energy of binding
by inserting two stacked molecules into the binding site. Second, the AATT site has
typically maintained a narrow, A-tract type minor groove, and a cooperative minor groove
dimer has not previously been observed for this sequence. This suggests that the wider
central GC sequence may allow compound module stacking while maintaining a relatively
narrow minor groove with only single compound modules inserted, as in Model 5C. The
compounds in this research have proved exciting new information on recognition of adjacent
AT binding sites as well as numerous suggestions for design of second generation agents
that have improved affinity and selectivity.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Structure of the compounds and the DNA sequences used in this study. For SPR
experiments 5′-biotin labeled DNA sequences are used.
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SPR binding affinity: A) SPR sensorgrams for the interaction of selected compounds with
AATT (upper panel) and AATTGCAATT (lower panel) DNA sequences. B) Comparison of
the SPR binding affinity for AATT (blue circles) and AATTGCAATT (red squares) DNA
sequences with different compounds. RU values from the steady–state region of SPR
sensorgrams are converted to r (r = RU/RUmax) and are plotted against the unbound
compound concentration (flow solution) for DB184, RT546, RT533 and DB2119. The lines
are the best fit values to a single site or two site interaction models and K values are in Table
1.
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The effect of compounds linker length changes on DNA binding: A) SPR sensorgrams for
the interaction of DNA sequences (AATT, AATTGAATT and AATTGCAATT) binding
with RT546 [-O-(CH2)3-O-], DB2115 [-O-(CH2)4-O-] and DB2114 [-O-(CH2)5-O-]. B)
Comparison of the SPR binding affinity for DNA sequences binding with compounds with
different linker length. The lines are the best fit values to a single site or two site interaction
models.
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Comparison of ESI-MS spectra of DNA sequences with RT546, RT533 and DB2119 at a
2:1 ratio (compound to DNA): A–D, the AATT DNA sequence; E–H, the AATTGAATT
DNA sequence; I–L, the AATTGCAATT DNA sequence. More detailed MS spectra are in
Supplementary Materials.
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Models for RT546 docked into the (A) AATTGAATT site, Model 2 in Figure 6; and (B) and
(C) the AATTGCAATT sequence (see Model 3 in Figure 6). The complex in (B) is highly
overlapped while in (C) the complex is offset. For clarity, the terminal bases are not
displayed in the images, and the images are of only the lowest-energy conformation. The
DNA backbone is shown by yellow ribbons and the GC base pairs are displayed by ball and
stick type in magenta, while the ligand is displayed as spacefill type in CPK colors. More
detailed modelling Figures of the models are in Supplementary Materials, Figure S6.
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Schematic representation of three different two-site binding modes for the compounds of
Figure 1. Model 1: single–site complexes - two molecules bind with “ideal” negative
cooperativity; Model 2: two–site complexes - single molecules bind to the entire sequence;
Model 3: two–site complexes - two molecules bind with strong positive cooperativity to the
entire sequence. The coloring scheme is green triangles for amidine groups, light blue ovals
for benzimidazole groups, red ovals for phenyl groups and dark blue lines for the linker.
Liu et al. Page 18



















Liu et al. Page 19
Table 1
Summary of SPR binding affinity and cooperativity factors for the interaction of selected compounds binding
with different two-site DNA sequences.
a
K = (K1 *K2)0.5
b
CF (Cooperativity Factor) = (K2/K1) × 4
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